Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000422290 | SCV000522572 | benign | not specified | 2016-09-02 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001522109 | SCV001731587 | benign | Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000676815 | SCV005249618 | benign | not provided | criteria provided, single submitter | not provided | ||
Mayo Clinic Laboratories, |
RCV000676815 | SCV000802625 | benign | not provided | 2016-02-26 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003912673 | SCV004734193 | benign | CA5A-related disorder | 2019-09-13 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |